Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 293, Issue 1, Pages L142-L150Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00434.2006
Keywords
cytokines; lung; newborn
Categories
Funding
- NHLBI NIH HHS [HL-56389, HL-61904, HL-74195, HL-64642] Funding Source: Medline
Ask authors/readers for more resources
Our previous work has shown that adult mice with overexpression of IL-6 and IL-13 in the lung have enhanced survival in hyperoxia associated with reduced hyperoxiainduced lung injury and cell death. We hypothesized that there are developmental differences in these responses in the adult vs. the newborn ( NB) animal, and these responses have clinical relevance in the human NB. We compared the responses to 100% O-2 of NB IL-6 and IL-13 transgenic mice with wild- type littermate controls by evaluating mortality, lung tissue TUNEL staining, and mRNA expression using RT- PCR. We used ELISA to measure IL-6 levels in tracheal aspirates from human neonates. Our results show that, in contrast to the cytoprotective effects in mature mice, IL-6 caused significantly increased mortality, DNA injury, caspases, cell death regulator and angiogenic factor expression in hyperoxia in the NB. Furthermore, tracheal aspirate levels of IL-6 were significantly increased in premature neonates with respiratory distress syndrome who had an adverse outcome ( bronchopulmonary dysplasia/ death). In contrast to the protective effects in adults, there was no survival advantage to the NB IL-13 mice in hyperoxia. These findings imply that caution should be exercised in extrapolating results from the adult to the NB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available